Healthcare AI company Innovaccer closed a $275 million Series F funding round, bringing its fundraising total to date to $675 million. The company has plans to go public “at some point,” but it isn’t in any hurry, said CEO Abhinav Shashank.
To keep up with the demand for its total artificial heart, Tucson-based Syncardia is in the midst of a Series F funding round, a spokesman said. This isn’t new technology. The company’s had Food and Drug Administration approval for the device for just about a decade; however, Syncardia says it’s the only approved total artificial heart […]
Zelis highlights how employers, payers, and consumers are integrating digital tools to manage healthcare costs.
Gene diagnostics megaplayer Invitae has raised a whopping $120 million in a Series F round – proof positive that startups operating in the vein of 23andMe are able to attract large swaths of cash. The company has a single diagnostic test that tests 200 genes for a variety of genetic disorders associated with cancer, cardiology, neurology and […]